Extending the Frontiers of Checkpoint Inhibition in Merkel Cell Carcinoma : vimarsana.com

In the treatment of unresectable or metastatic Merkel cell carcinoma, immune checkpoint inhibitors have activity and tolerability.

Related Keywords

Boston , Massachusetts , United States , Netherlands , Dana Farber Cancer Institute , Germany , American , Avelumab Bavencio , Jamesa Decaprio , Kangc Retifanlimab , American Society Of Clinical Oncology Annual Meeting , Harvard Medical School , Merkel Cell Carcinoma Center , Approved Agents , Dual Checkpoint , Clinical Oncology Annual , Harvard Medical , Cancer Immunol , Clin Cancer , Unresectable Or Metastatic Merkel Cell Carcinoma , Dana Farber Cancer Institute , Annw Silk , D , S , Harvard Medical School ,